MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,787,659 | +27.4% | 41,039 | +5.7% | 0.10% | +32.0% |
Q2 2023 | $1,403,072 | +19.7% | 38,834 | +23.2% | 0.08% | +4.2% |
Q1 2023 | $1,172,174 | +347.6% | 31,527 | +445.4% | 0.07% | +323.5% |
Q4 2022 | $261,892 | -31.3% | 5,780 | +5.9% | 0.02% | -37.0% |
Q3 2022 | $381,000 | -0.5% | 5,457 | -4.4% | 0.03% | +12.5% |
Q2 2022 | $383,000 | -24.8% | 5,711 | -7.7% | 0.02% | +14.3% |
Q1 2022 | $509,000 | -49.1% | 6,190 | -9.2% | 0.02% | -36.4% |
Q4 2021 | $1,000,000 | -24.1% | 6,816 | -8.5% | 0.03% | -25.0% |
Q3 2021 | $1,318,000 | +488.4% | 7,450 | +469.6% | 0.04% | +388.9% |
Q1 2021 | $224,000 | +12.0% | 1,308 | +43.4% | 0.01% | 0.0% |
Q4 2020 | $200,000 | – | 912 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |